Actionable Stock Market Trading Newswire. Built for Traders, by Traders.
All news is property of their respective owners.

Home Newsfeeds Stifel Downgrades Imago BioSciences to Hold, Raises Price Target to $36

Stifel Downgrades Imago BioSciences to Hold, Raises Price Target to $36

Stifel analyst Stephen Willey downgrades Imago BioSciences (NASDAQ:IMGO) from Buy to Hold and raises the price target from $35 to $36.

November 28, 2022

1 minute read

Stifel analyst Stephen Willey downgrades Imago BioSciences (NASDAQ:IMGO) from Buy to Hold and raises the price target from $35 to $36.

This Week In AI: Wall Street, Cancer Cure And Big Tech’s AI Developments

July 23, 5:04 AM

This week in artificial intelligence was marked by the potential of AI replacing Wall Street traders, the use…

May 2, 4:01 PM

Over the past 3 months, 12 analysts have published their opinion on Chegg (NYSE:CHGG) stock. These analysts are…

March 6, 9:13 AM

RBC Capital analyst Ashish Sabadra reiterates S&P Global (NYSE:SPGI) with a Outperform and maintains $434 price target.

June 13, 8:21 AM

During times of turbulence and uncertainty in the markets, even when markets are at all-time highs, many investors…